Perkins Coie Trust Company’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11
Closed -$163 417
2025
Q1
$163 Buy
+11
New +$169 ﹤0.01% 437
2023
Q4
Sell
-10
Closed -$173 500
2023
Q3
$173 Buy
10
+9
+900% +$188 ﹤0.01% 583
2023
Q2
$20 Hold
1
﹤0.01% 230
2023
Q1
$23 Hold
1
﹤0.01% 239
2022
Q4
$27 Hold
1
﹤0.01% 227
2022
Q3
$0 Hold
1
﹤0.01% 237
2022
Q2
$0 Hold
1
﹤0.01% 238
2022
Q1
$0 Hold
1
﹤0.01% 238
2021
Q4
$0 Sell
1
-402
-100% -$13.1K ﹤0.01% 259
2021
Q3
$13K Sell
403
-209
-34% -$6.69K ﹤0.01% 199
2021
Q2
$19K Buy
+612
New +$20.1K 0.01% 201

Other funds holding OGN

Perkins Coie Trust Company's OGN Position: Q2 2025 in Review

Perkins Coie Trust Company sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 11 shares — an estimated $163 sold.

Perkins Coie Trust Company first reported a position in OGN in Q2 2021 and held it in 11 quarters. The position peaked at $19K in Q2 2021. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Perkins Coie Trust Company reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Perkins Coie Trust Company sold 11 Organon & Co shares in Q2 2025, an estimated $163.
  • Perkins Coie Trust Company first reported a position in Organon & Co in Q2 2021 and held it in 11 quarters.
  • Perkins Coie Trust Company's Organon & Co position peaked at $19K in Q2 2021.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Perkins Coie Trust Company's 13F filing for Q2 2025, filed 10 Jul 2025.